135 related articles for article (PubMed ID: 16428541)
1. Dexmedetomidine-induced decreases in accumbal dopamine in the rat are partly mediated via the locus coeruleus.
Whittington RA; Virág L
Anesth Analg; 2006 Feb; 102(2):448-55. PubMed ID: 16428541
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine decreases extracellular dopamine concentrations in the rat nucleus accumbens.
Whittington RA; Virag L; Morishima HO; Vulliemoz Y
Brain Res; 2001 Nov; 919(1):132-8. PubMed ID: 11689170
[TBL] [Abstract][Full Text] [Related]
3. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
[TBL] [Abstract][Full Text] [Related]
4. In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse nucleus accumbens.
Ihalainen JA; Tanila H
J Neurochem; 2004 Oct; 91(1):49-56. PubMed ID: 15379886
[TBL] [Abstract][Full Text] [Related]
5. The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis.
Hemby SE; Martin TJ; Co C; Dworkin SI; Smith JE
J Pharmacol Exp Ther; 1995 May; 273(2):591-8. PubMed ID: 7752060
[TBL] [Abstract][Full Text] [Related]
6. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
Devoto P; Flore G; Pira L; Diana M; Gessa GL
Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens.
Quarta D; Di Francesco C; Melotto S; Mangiarini L; Heidbreder C; Hedou G
Neurochem Int; 2009 Feb; 54(2):89-94. PubMed ID: 19118592
[TBL] [Abstract][Full Text] [Related]
8. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Longu G; Pira L; Gessa GL
Synapse; 2003 Dec; 50(3):200-5. PubMed ID: 14515337
[TBL] [Abstract][Full Text] [Related]
9. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
Navailles S; Moison D; Ryczko D; Spampinato U
J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
[TBL] [Abstract][Full Text] [Related]
10. S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.
Millan MJ; Lejeune F; Gobert A; Brocco M; Auclair A; Bosc C; Rivet JM; Lacoste JM; Cordi A; Dekeyne A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1206-22. PubMed ID: 11082458
[TBL] [Abstract][Full Text] [Related]
11. The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens.
Rahman S; Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT
Neuropharmacology; 2007 Mar; 52(3):755-63. PubMed ID: 17097117
[TBL] [Abstract][Full Text] [Related]
12. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
[TBL] [Abstract][Full Text] [Related]
13. Intravenous dexmedetomidine decreases lung permeability induced by intracranial hypertension in rats.
Kumagai M; Horiguchi T; Nishikawa T; Masaki Y; Tobe Y
Anesth Analg; 2008 Aug; 107(2):643-7. PubMed ID: 18633046
[TBL] [Abstract][Full Text] [Related]
14. Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens.
De Deurwaerdère P; Moison D; Navailles S; Porras G; Spampinato U
J Neurochem; 2005 Jul; 94(1):140-9. PubMed ID: 15953357
[TBL] [Abstract][Full Text] [Related]
15. The α₁-, but not α₂-, adrenoceptor in the nucleus accumbens plays an inhibitory role upon the accumbal noradrenaline and dopamine efflux of freely moving rats.
Saigusa T; Aono Y; Uchida T; Takada K; Verheij MM; Koshikawa N; Cools AR
Eur J Pharmacol; 2012 Aug; 688(1-3):35-41. PubMed ID: 22617026
[TBL] [Abstract][Full Text] [Related]
16. Taurine elevates dopamine levels in the rat nucleus accumbens; antagonism by strychnine.
Ericson M; Molander A; Stomberg R; Söderpalm B
Eur J Neurosci; 2006 Jun; 23(12):3225-9. PubMed ID: 16820013
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
[TBL] [Abstract][Full Text] [Related]
18. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Scalori V; Corsini GU
Ann N Y Acad Sci; 1998 May; 844():166-77. PubMed ID: 9668674
[TBL] [Abstract][Full Text] [Related]
19. Synergistic, but not separate, stimulation of accumbal β1- and β2-adrenoceptors alters the accumbal dopamine efflux in freely moving rats.
Aono Y; Saigusa T; Taguchi H; Uchida T; Takada K; Koshikawa N; Cools AR
Eur J Pharmacol; 2013 Sep; 715(1-3):363-9. PubMed ID: 23665498
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus.
Guiard BP; El Mansari M; Blier P
Mol Pharmacol; 2008 Nov; 74(5):1463-75. PubMed ID: 18703671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
